g****e
发帖数: 1426 | 1 AF使劲打压，结果会好. 但股价不好说。我上周五卖了不再持有。
同时另外NASH股票CEMP, ICPT和GLMD今天都绿，值得关注。特别是GLMD(今天差点爆了
）和CEMP(明天盘后ER） |
|
g****e
发帖数: 1426 | 2 GLMD, GALT, ICPT, CEMP, RPTP 蓄势待发
Catalyst: GALT top-line result due by the end of July。
To date, Galectin has completed enrollment for the second cohort in an early
stage trial for GR-MD-02 as a potential treatment for NASH, with a top-line
data readout expected by the end of this month. Previously, the company
reported that the initial cohort of patients receiving the drug showed that
it was both safe and well tolerated.
除RPTP本人都持有，相对而言GALT风险最大。
仅供参考信息共享，投资风险自负！Good luck! |
|
f**********c
发帖数: 25 | 3 ACCO， target $11
GSVC, target $16
CEMP, target $17
TWOU, target $20
LOXO, target $20 |
|
W***n
发帖数: 11530 | 4 4 Biotech Catalyst Stocks to Buy With 60% to 100% Upside Potential
By Lee Jackson November 20, 2014 8:55 am EST
In the world of biotech investing, there are some sure-fire ways for stocks
to move. Pipeline announcements, clinical data and regulatory approval all
can move the needle as catalysts for stocks in the industry. A new report
from the biotech team at Stifel has a self-described plethora of catalysts
from companies that are presenting at the firm’s annual health care
conference.
We sc... 阅读全帖 |
|
l*****g
发帖数: 391 | 5 你赚美了 ！BIIB 今天表现不错。CEMP 表现也不错，是 FENGYUN药王 和 股哥偏爱的
股票。
我手里有几个药股，都是绿的、即将上爆的。选股票我是基于FA， 股票买入点，则是
根据我自己的TA判断。 |
|
t*****e
发帖数: 380 | 6 cemp的PIII的trial什么时候top line？ |
|
l*****g
发帖数: 391 | 7 只看了过去的信息。February 5, 2016, Cempra, Inc. (NASDAQ:CEMP), a clinical-
stage
pharmaceutical company focused on developing antibiotics in the face of
rising antibiotic resistant bacterial infections, today announced the
publication of positive results from its pivotal Phase 3 clinical trial of
solithromycin oral capsules in the treatment of patients with community-
acquired bacterial pneumonia (CABP) in The Lancet Infectious Diseases.
今天捞底了ALNY。我的初级TA分析结果是，这个股票已经筑底一段时间，现在买入，收
益大于风险。我重仓的都是次新股。这个ALNY我只... 阅读全帖 |
|
